Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683876 · ClinicalTrials.gov registry record
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
A clinical trial of Nutritional and Metabolic Diseases, sponsored by Mebo Research.
- Completed
- Registry status
- 39
- Enrollment target
- 2
- Study locations
NCT02683876: Completed study of Nutritional and Metabolic Diseases, sponsored by Mebo Research.
NCT02683876 is a study of Nutritional and Metabolic Diseases that has completed, run by Mebo Research. The registered enrollment target is 39 participants, below the 72-participant average among 4 other Nutritional and Metabolic Diseases trials with a reported enrollment target (46% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02683876, a study of Nutritional and Metabolic Diseases, has completed, sponsored by Mebo Research.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to identify metabolic signatures associated with malodor conditions. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore if conditions leading to malodor can be screened by metabolomic profiling of urine samples.
Primary Outcome
The investigators would like to validate if urine metabolomic profiling can be used for identifying key metabolomic signatures associated with malodor. Differences in metabolite concentrations will be measured by mass spectrometry, to compare urine samples from individuals with malodor issues, and age-matched healthy controls.
Conditions Studied
Study Locations (2)
Florida
- MeBO Research - Miami
Alberta
- The Metabolomics Innovation Centre - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-05 |
What the finished NCT02683876 record still lists
NCT02683876 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 72-participant average among 4 other Nutritional and Metabolic Diseases trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Nutritional and Metabolic Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02683876 reports a single indexed study location in Florida, Alberta.
Frequently Asked Questions
What is clinical trial NCT02683876 about?
NCT02683876 is a clinical study titled "Exploratory Study of Relationships Between Malodor and Urine Metabolomics". The purpose of this study is to identify metabolic signatures associated with malodor conditions. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore if conditions leading to malodor can be screened by metabolomic profiling of urine samples.
What is the current status of trial NCT02683876?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2016-02. Estimated completion is 2018-05.
What conditions does trial NCT02683876 study?
This clinical trial studies the following conditions: Nutritional and Metabolic Diseases.
Who is sponsoring clinical trial NCT02683876?
This trial is sponsored by Mebo Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02683876 being conducted?
This trial has 2 study locations across Florida, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nutritional and Metabolic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized GI Motility Responses to Diet
RECRUITING · NA
-
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes
RECRUITING · NA
-
The Maternal Well-Being Study
ACTIVE NOT RECRUITING · NA
-
Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia